Deep minimal residual disease assessment redefines outcome and unveils different modes of treatment resistance in standard and high-risk multiple myeloma
Ontology highlight
ABSTRACT: Deep minimal residual disease assessment redefines outcome and unveils different modes of treatment resistance in standard and high-risk multiple myeloma
PROVIDER: PRJNA613235 | ENA |
REPOSITORIES: ENA
ACCESS DATA